XML 9 R2.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 6,882 $ 22,808
Short-term investments 62,790 110,528
Prepaid expenses and other current assets 4,038 2,352
Total current assets 73,710 135,688
Operating lease asset, net 358 613
In-process research and development 32,386 32,386
Other assets 185 322
Total assets 106,639 169,009
Current liabilities:    
Accounts payable 2,842 3,627
Current operating lease liabilities 341 358
Accrued expenses and other liabilities 8,519 14,359
Total current liabilities 11,702 18,344
Deferred tax liabilities 2,187 2,187
Non-current operating lease liabilities 35 283
Warrant liabilities 22,901 11,416
Total liabilities 36,825 32,230
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, $0.001 par value, 450,000,000 shares authorized at September 30, 2026 and 300,000,000 shares authorized at December 31, 2025; 81,442,402 and 75,430,033 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively 82 75
Additional paid-in capital 506,631 482,189
Accumulated other comprehensive income (loss) (126) 24
Accumulated deficit (475,791) (401,203)
Total stockholders’ equity 30,796 81,085
Total liabilities, convertible preferred stock and stockholders' equity 106,639 169,009
Series X1 Non-voting Convertible Preferred Stock [Member]    
Current liabilities:    
Convertible preferred stock, value 36,867 53,543
Series X Non-Voting Convertible Preferred Stock [Member]    
Current liabilities:    
Convertible preferred stock, value $ 2,151 $ 2,151